Does TriVascular address an opportunity that justifies the new investments by MPM Capital and NEA? Is it feasible to address a broader patient population requiring endovascular repair of aortic aneurysms with the novel stent-graft from TriVascular? Will these patients have a safe and permanent alternative to open surgical repair?
IIP > read on here > http://www.pressdemocrat.com…
… […]